<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the extent to which peripheral polymorphonuclear leukocytes (PMNs) contributed to <z:mp ids='MP_0003674'>oxidative stress</z:mp> (OS) and <z:mp ids='MP_0001845'>inflammation</z:mp> in type 2 diabetic patients </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: PMNs and plasma were separated from blood withdrawn from 18 type 2 diabetic patients and 16 age- and sex-matched <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects </plain></SENT>
<SENT sid="2" pm="."><plain>The rate of <z:chebi fb="1" ids="18421">superoxide</z:chebi> release from <z:chebi fb="0" ids="8116">phorbol</z:chebi> 12-<z:chebi fb="0" ids="30807">myristate</z:chebi> 13-<z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="1" ids="53780">PMA</z:chebi>)-stimulated PMNs and the plasma <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH) levels served as measures of OS </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> was assessed by PMN recruitment, expressed by peripheral blood PMN counts, and the in vitro survival of PMNs, which reflects cell <z:mp ids='MP_0001651'>necrosis</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:chebi fb="1" ids="53780">PMA</z:chebi>-stimulated PMNs from <z:mp ids='MP_0002055'>diabetes</z:mp> released <z:chebi fb="1" ids="18421">superoxide</z:chebi> significantly faster, and plasma-reduced GSH was lower in diabetic patients than in <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects </plain></SENT>
<SENT sid="5" pm="."><plain>The rate of <z:chebi fb="1" ids="18421">superoxide</z:chebi> release from diabetic PMNs showed no correlation with the plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations, whereas a positive linear correlation with HbA1c was found </plain></SENT>
<SENT sid="6" pm="."><plain>The in vitro survival of diabetic PMNs was lower than <z:mpath ids='MPATH_458'>normal</z:mpath> control PMNs when each was incubated in its own serum </plain></SENT>
<SENT sid="7" pm="."><plain>The in vitro survival of <z:mpath ids='MPATH_458'>normal</z:mpath> control PMNs was reduced when incubated with diabetic serum, whereas <z:mpath ids='MPATH_458'>normal</z:mpath> control sera promoted the survival of diabetic PMNs </plain></SENT>
<SENT sid="8" pm="."><plain>Peripheral PMN counts were higher in diabetic patients than in <z:mpath ids='MPATH_458'>normal</z:mpath> control patients </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is accompanied by a priming of PMNs, resulting in OS and increased self-<z:mp ids='MP_0001651'>necrosis</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain><z:mp ids='MP_0001651'>Necrosis</z:mp> starts a chain of inflammatory reactions that result in cell recruitment and in the long run, with OS, may result in <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Understanding the contribution of PMNs to OS and <z:mp ids='MP_0001845'>inflammation</z:mp> in <z:mp ids='MP_0002055'>diabetes</z:mp> may illuminate new mechanisms through which <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> evolves and causes <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">angiopathy</z:e> and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
</text></document>